{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:24:12Z","timestamp":1792027452988,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008173","name":"Intermountain Research and Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UM1TR004409"],"award-info":[{"award-number":["UM1TR004409"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["chestcc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST Critical Care"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.chstcc.2025.100178","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T11:33:19Z","timestamp":1747827199000},"page":"100178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Protocol and Statistical Analysis Plan for the Vasopressin for Septic Shock Pragmatic (VASSPR) Cluster-Crossover Randomized Trial"],"prefix":"10.1016","volume":"3","author":[{"given":"Ithan D.","family":"Peltan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Groat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth H.","family":"Tillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben J.","family":"Brintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Chauv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Beesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer H.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Arizmendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliotte L.","family":"Hirshberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Lanspa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Bledsoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin T.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmony","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara D.","family":"Moores Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Klippel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Semler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin K.","family":"Grissom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay M.","family":"Leither","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.chstcc.2025.100178_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"10219","key":"10.1016\/j.chstcc.2025.100178_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.chstcc.2025.100178_bib3","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.2014.2637","article-title":"Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012","volume":"311","author":"Kaukonen","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.chstcc.2025.100178_bib4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.chest.2016.07.010","article-title":"Estimating ten-year trends in septic shock incidence and mortality in United States academic medical centers using clinical data","volume":"151","author":"Kadri","year":"2017","journal-title":"Chest"},{"issue":"13","key":"10.1016\/j.chstcc.2025.100178_bib5","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.2017.13836","article-title":"Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014","volume":"318","author":"Rhee","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.chstcc.2025.100178_bib6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1164\/rccm.202309-1636OC","article-title":"Temporal trends in mortality of critically ill patients with sepsis in the United Kingdom, 1988-2019","volume":"209","author":"Prescott","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.chstcc.2025.100178_bib7","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00134-020-06151-x","article-title":"Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis","volume":"46","author":"Fleischmann-Struzek","year":"2020","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.chstcc.2025.100178_bib8","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1378\/chest.12-1106","article-title":"Survival after shock requiring high-dose vasopressor therapy","volume":"143","author":"Brown","year":"2013","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.chstcc.2025.100178_bib9","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.chstcc.2025.100178_bib10","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1164\/rccm.201604-0862CP","article-title":"Potentially inadvertent immunomodulation: norepinephrine use in sepsis","volume":"194","author":"Stolk","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chstcc.2025.100178_bib11","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1164\/rccm.202002-0339OC","article-title":"Norepinephrine dysregulates the immune response and compromises host defense during sepsis","volume":"202","author":"Stolk","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chstcc.2025.100178_bib12","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/iai.62.5.2046-2050.1994","article-title":"Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood","volume":"62","author":"van der Poll","year":"1994","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.chstcc.2025.100178_bib13","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/01.CIR.95.5.1108","article-title":"Role of vasopressin deficiency in the vasodilation of septic shock","volume":"95","author":"Reid","year":"1997","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.chstcc.2025.100178_bib14","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00134-019-05620-2","article-title":"Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials","volume":"45","author":"Nagendran","year":"2019","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.chstcc.2025.100178_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ccc.2018.11.004","article-title":"Vasopressin in vasodilatory shock","volume":"35","author":"Ukor","year":"2019","journal-title":"Crit Care Clin"},{"issue":"3","key":"10.1016\/j.chstcc.2025.100178_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/phar.2220","article-title":"Vasoactive agent use in septic shock: beyond first-line recommendations","volume":"39","author":"Sacha","year":"2019","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.chstcc.2025.100178_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0885066609340519","article-title":"Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress","volume":"24","author":"Dunser","year":"2009","journal-title":"J Intensive Care Med"},{"issue":"3","key":"10.1016\/j.chstcc.2025.100178_bib18","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1378\/chest.120.3.989","article-title":"Physiology of vasopressin relevant to management of septic shock","volume":"120","author":"Holmes","year":"2001","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chstcc.2025.100178_bib19","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","article-title":"Vasopressin deficiency contributes to the vasodilation of septic shock","volume":"95","author":"Landry","year":"1997","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.chstcc.2025.100178_bib20","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis","volume":"319","author":"McIntyre","year":"2018","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.chstcc.2025.100178_bib21","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.chstcc.2025.100178_bib22","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1513\/AnnalsATS.202102-196OC","article-title":"Practice patterns in the initiation of secondary vasopressors and adjunctive corticosteroids during septic shock in the United States","volume":"18","author":"Bosch","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"10","key":"10.1016\/j.chstcc.2025.100178_bib23","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1513\/AnnalsATS.201604-259OC","article-title":"Epidemiology of vasopressin use for adults with septic shock","volume":"13","author":"Vail","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.chstcc.2025.100178_bib24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/CCM.0000000000005305","article-title":"Association between vasopressin rebranding and utilization in patients with septic shock","volume":"50","author":"Sacha","year":"2022","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.chstcc.2025.100178_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2146\/ajhp160460","article-title":"Rebranding of generic parenteral vasopressin: Effect on clinician practices and perceptions","volume":"74","author":"Curtis","year":"2017","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"10.1016\/j.chstcc.2025.100178_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/0897190018770062","article-title":"Hyperinflation of vasopressors (vasopressin, norepinephrine, ephedrine, etc)","volume":"31","author":"Quan","year":"2018","journal-title":"J Pharm Pract"},{"issue":"1","key":"10.1016\/j.chstcc.2025.100178_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1060028016669163","article-title":"Efficacy and outcomes after vasopressin guideline implementation in septic shock","volume":"51","author":"Wu","year":"2017","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.chstcc.2025.100178_bib28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Ann Intern Med"},{"issue":"23","key":"10.1016\/j.chstcc.2025.100178_bib29","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/jama.2022.21243","article-title":"Guidelines for reporting outcomes in trial protocols: the SPIRIT-Outcomes 2022 extension","volume":"328","author":"Butcher","year":"2022","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.chstcc.2025.100178_bib30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/CCM.0000000000006176","article-title":"Position paper on the reporting of norepinephrine formulations in critical care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force","volume":"52","author":"Wieruszewski","year":"2024","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.chstcc.2025.100178_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.201212-2199OC","article-title":"Multicenter implementation of a severe sepsis and septic shock treatment bundle","volume":"188","author":"Miller","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chstcc.2025.100178_bib33","first-page":"1","article-title":"Building a comprehensive clinical information system from components: the approach at Intermountain Health Care","volume":"42","author":"Clayton","year":"2003","journal-title":"Methods Inf Med"},{"issue":"12","key":"10.1016\/j.chstcc.2025.100178_bib34","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/cid\/ciad101","article-title":"Concordance between initial presumptive and final adjudicated diagnoses of infection among patients meeting Sepsis-3 criteria in the emergency department","volume":"76","author":"Hooper","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.chstcc.2025.100178_bib35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.annemergmed.2018.10.007","article-title":"Emergency department crowding is associated with delayed antibiotics for sepsis","volume":"73","author":"Peltan","year":"2019","journal-title":"Ann Emerg Med"},{"issue":"5","key":"10.1016\/j.chstcc.2025.100178_bib36","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.chest.2019.02.008","article-title":"ED door-to-antibiotic time and long-term mortality in sepsis","volume":"155","author":"Peltan","year":"2019","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.chstcc.2025.100178_bib37","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1513\/AnnalsATS.202403-286OC","article-title":"Effectiveness and safety of an emergency department code sepsis protocol: a pragmatic clinical trial","volume":"21","author":"Peltan","year":"2024","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.chstcc.2025.100178_bib38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"12","key":"10.1016\/j.chstcc.2025.100178_bib39","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1097\/CCM.0000000000004023","article-title":"Vasopressin versus norepinephrine for the management of septic shock in cancer patients: the VANCS II randomized clinical trial","volume":"47","author":"Hajjar","year":"2019","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.chstcc.2025.100178_bib40","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.chstcc.2025.100178_bib41","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/jama.2019.14607","article-title":"Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: the SEPSIS-ACT randomized clinical trial","volume":"322","author":"Laterre","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.chstcc.2025.100178_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/kisup.2012.7","article-title":"KDIGO clinical practice guidelines for acute kidney injury: summary of recommendation statements","volume":"2","year":"2012","journal-title":"Kidney International Supplements"},{"issue":"2","key":"10.1016\/j.chstcc.2025.100178_bib43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/CCM.0000000000005721","article-title":"Mortality as a measure of treatment effect in clinical trials recruiting critically ill patients","volume":"51","author":"Friedrich","year":"2023","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.chstcc.2025.100178_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12874-016-0217-0","article-title":"Performance of models for estimating absolute risk difference in multicenter trials with binary outcome","volume":"16","author":"Pedroza","year":"2016","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.chstcc.2025.100178_bib45","series-title":"Handbook for Advanced Multilevel Analysis","first-page":"163","article-title":"Bootstrapping in multilevel models","author":"Goldstein","year":"2011"},{"issue":"6","key":"10.1016\/j.chstcc.2025.100178_bib46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/bjc.1976.220","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design","volume":"34","author":"Peto","year":"1976","journal-title":"Br J Cancer"},{"issue":"526","key":"10.1016\/j.chstcc.2025.100178_bib47","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1259\/0007-1285-44-526-793","article-title":"Repeated assessment of results in clinical trials of cancer treatment","volume":"44","author":"Haybittle","year":"1971","journal-title":"Br J Radiol"},{"issue":"9471","key":"10.1016\/j.chstcc.2025.100178_bib48","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(05)66516-6","article-title":"Multiplicity in randomised trials II: subgroup and interim analyses","volume":"365","author":"Schulz","year":"2005","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.chstcc.2025.100178_bib49","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1503\/cmaj.071366","article-title":"Serious adverse events in academic critical care research","volume":"178","author":"Cook","year":"2008","journal-title":"CMAJ"}],"container-title":["CHEST Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949788425000516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949788425000516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:34:08Z","timestamp":1774870448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949788425000516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2949788425000516"],"URL":"https:\/\/doi.org\/10.1016\/j.chstcc.2025.100178","relation":{},"ISSN":["2949-7884"],"issn-type":[{"value":"2949-7884","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol and Statistical Analysis Plan for the Vasopressin for Septic Shock Pragmatic (VASSPR) Cluster-Crossover Randomized Trial","name":"articletitle","label":"Article Title"},{"value":"CHEST Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chstcc.2025.100178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100178"}}